Leucine
The amino-acid trigger for muscle protein synthesis — that rarely builds extra muscle on its own.
What is Leucine?
Leucine (L-Leucine) is a performance supplement used for stimulates muscle protein synthesis. NutriDex grades the human evidence as Mixed. Leucine is one of three branched-chain amino acids and the strongest single trigger of muscle protein synthesis through the mTORC1 pathway. In short metabolic studies it consistently raises the muscle fractional synthetic rate, which fuels its reputation as a muscle-building supplement. However, that signal seldom translates into measurable results: meta-analyses in older adults found isolated leucine produced no change in lean body mass (WMD ~0.03 kg) and no clear strength gain, and controlled trials in young trainees eating enough protein show free leucine adds nothing over placebo for muscle size or strength. Benefits appear mainly when leucine is paired with adequate protein, resistance exercise, and sometimes vitamin D — and in sarcopenia, where modest gains in grip strength and gait speed are seen. BCAA mixtures (rich in leucine) modestly reduce post-exercise soreness. Its best-proven clinical role is BCAA therapy for hepatic encephalopathy, not athletic performance.
Purported Benefits
Evidence by outcome
The same supplement can be well-proven for one use and unproven for another — here is the human evidence graded outcome by outcome.
| Outcome | Evidence | Effect | Studies |
|---|---|---|---|
| Muscle protein synthesis (acute)Consistently raises fractional synthetic rate in metabolic studies, but this signal rarely translates to mass. | Moderate | ↑ benefit · moderate | 1 |
| Lean mass / strength gainMeta-analyses and an RCT show isolated leucine adds no lean mass or strength when protein is adequate. | Moderate | — no effect · negligible | 2 |
| Sarcopenia (with protein/vitamin D)Sarcopenia meta-analysis showed modest grip-strength/gait gains; benefit largely requires vitamin D pairing. | Preliminary | ↑ benefit · small | 2 |
| Post-exercise soreness (BCAA-rich)BCAA meta-analysis cut soreness/CK, but a free-leucine RCT found no recovery benefit in untrained adults. | Mixed | ↔ mixed · small | 2 |
| Hepatic encephalopathy (BCAA therapy)Cochrane review (16 trials): BCAA improved encephalopathy (RR 0.73) though did not reduce mortality. | Strong | ↑ benefit · moderate | 1 |